Proctitis

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: The Prevalence of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Patients Suspected of Hemorrhagic Proctosigmoiditis

  An observational clinical trial sponsored by the University of Aarhus aims to determine how prevalent Chlamydia trachomatis and Neisseria go…

• FDA approval · 2023-09-12
  FDA Approved: MESALAMINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

  FDA approved a supplemental application for Mesalamine from Camber Pharmaceuticals, indicating an approved change to an existing generic pro…

• FDA approval · 2023-05-12
  FDA Approved: MESALAMINE — Original Application (Lannett Company Inc.)

  FDA approval of a generic mesalamine product from Lannett Company Inc. (Original Application).

• FDA approval · 2022-06-03
  FDA Approved: MESALAMINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for mesalamine filed by Mylan Pharmaceuticals Inc.

• CLINICAL_TRIALS trial_result · 2019-08-14
  Clinical Trial Update: The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis [Phase 3]

  Phase 3 trial assessing safety and tolerability of budesonide foam in participants with active proctitis or proctosigmoiditis was terminated…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-03-27
  Clinical Trial Update: Clinical Trial With Mesalamine 1g Suppositories [Phase 3]

  A Phase 3 trial of mesalamine 1 g suppositories for proctitis has been terminated.

• CLINICAL_TRIALS trial_result · 2015-06-23
  Clinical Trial Update: Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis [Phase 2]

  A Phase 2 trial evaluating the safety and feasibility of the Photopill Capsule for ulcerative proctitis (a form of ulcerative colitis) has c…